Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial hyperprolactinemia is a rare, genetic endocrine disorder characterized by persistently high prolactin serum levels (not associated with gestation, puerperium, drug intake or pituitary tumor) in multiple affected family members. Clinically it manifests with signs usually observed in hyperprolactinemia, which are: secondary medroxyprogesterone acetate (MPA)-negative amenorrhea and galactorrhea in female patients, and hypogonadism and decreased testosterone level-driven sexual disfunction in male patients. Oligomenorrhea and primary infertility have also been reported in some female patients.
Features include always present findings: Increased circulating prolactin concentration; and common findings: Menorrhagia, Female infertility, Oligomenorrhea, and Galactorrhea. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 1 | Increased circulating prolactin concentration |
PRLR function has not been fully characterized.
Familial hyperprolactinemia is associated with mutations in the PRLR gene on chromosome 5.
Genetic testing for PRLR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for familial hyperprolactinemia has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 4 common features.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE3, 1 PHASE1. Research is primarily industry-sponsored.
103 publications have been identified in PubMed for familial hyperprolactinemia. Research spans Review / Meta-Analysis (33%), Epidemiology / Natural History (21%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 33 | 33% |
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 12:44 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Hormones
1 |
Female infertility |
Disease patterns and progression |
21 |
21% |
Laboratory research | 18 | 18% |
Clinical study results | 17 | 17% |
Testing and diagnosis research | 6 | 6% |
Patient case studies | 4 | 4% |
New treatment approaches | 1 | 1% |
Stumpf MAM (2026). [PMID: 41565497](https://pubmed.ncbi.nlm.nih.gov/41565497/). *Best Pract Res Clin Endocrinol Metab*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41918976](https://pubmed.ncbi.nlm.nih.gov/41918976/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Glezer A (2026). [PMID: 41234156](https://pubmed.ncbi.nlm.nih.gov/41234156/). *The Journal of clinical endocrinology and metabolism*. [Review / Meta-Analysis]
Adıgüzel S (2026). [PMID: 41882957](https://pubmed.ncbi.nlm.nih.gov/41882957/). *J Child Adolesc Psychopharmacol*. [Review / Meta-Analysis]
Paragliola RM (2026). [PMID: 41328476](https://pubmed.ncbi.nlm.nih.gov/41328476/). *Clinical endocrinology*. [Basic Science / Preclinical]
Kaul I (2026). [PMID: 41634905](https://pubmed.ncbi.nlm.nih.gov/41634905/). *Am J Psychiatry*. [Clinical Trial Publication]
Samson SL (2026). [PMID: 41904067](https://pubmed.ncbi.nlm.nih.gov/41904067/). *Best Pract Res Clin Endocrinol Metab*. [Review / Meta-Analysis]
Aly El-Gabry D (2026). [PMID: 41762719](https://pubmed.ncbi.nlm.nih.gov/41762719/). *Int Clin Psychopharmacol*. [Basic Science / Preclinical]
Zhao G (2026). [PMID: 41152254](https://pubmed.ncbi.nlm.nih.gov/41152254/). *The American journal of psychiatry*. [Basic Science / Preclinical]
Sharma M (2026). [PMID: 34662078](https://pubmed.ncbi.nlm.nih.gov/34662078/). *Unknown Journal*. [Clinical Trial Publication]